Aripiprazole in childhood and adolescence for Tourette syndrome.
Duane
Drake D
DD
D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D001288:Attention / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002648:Child; D002652:Child Behavior / Q000187:drug effects; D003071:Cognition / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011595:Psychomotor Agitation; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D005879:Tourette Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole